(792) Does Right Ventricular Support with Mechanical Assist Devices Compromise Outcome for Heart Transplantation?

PurposeRight ventricular (RV) failure is uncommon in patients awaiting heart transplantation (HTx). However, this small group of may require the placement a durable RVAD or temporary (tRVAD). It has not been well-established as to waitlist mortality post-transplant course for these patients.MethodsBetween 2012 and 2020, we assessed 20 who developed RV requiring (n=3) (tRVAD, n=17). The tRVAD included following: Impella RP (n=6), CentriMag TandemHeart (n=5). These were 3- 6-month on waitlist, if transplanted, survival at 30-days 1-year post-transplant. A case-controlled matched age, gender era without mechanical circulatory support (MCS) prior transplant was used control.ResultsPatients with assist devices compared MCS (control) had similar waitlist. Post-transplant, comparable 30 days control patients.ConclusionRV supported significant risk candidacy (waitlist mortality) outcome. Larger studies are needed confirm findings. Right patients. Between control. Patients